US2009318512A1PendingUtilityA1

Methods of maintaining ocular tissue cell membrane integrity using cetylpyridinium chloride

Assignee: ADVANCED MEDICAL OPTICS INCPriority: Apr 7, 2004Filed: May 21, 2009Published: Dec 24, 2009
Est. expiryApr 7, 2024(expired)· nominal 20-yr term from priority
A61P 43/00A61P 27/02C11D 3/349C11D 3/48C11D 1/008C11D 3/0078A01N 43/40A61L 12/143C11D 3/222A61L 12/145C11D 3/3409A61L 12/14C11D 3/28A61P 31/04
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A multi-purpose contact lens care solution having high antimicrobial activity comprising, in an aqueous liquid medium, cetylpyridinium chloride and a non-ionic surfactant. In one embodiment of the invention, the non-ionic surfactant is a poly(oxypropylene)-poly(oxyethylene) block copolymer. The solution may optionally also include additional antimicrobial components, a buffer component, a viscosity inducing component, a surfactant, taurine, propylene glycol and/or a tonicity component. This solution additionally prevents losses in ocular tissue membrane integrity during contact lens wear.

Claims

exact text as granted — not AI-modified
1 - 13 . (canceled) 
     
     
         14 . A method for maintaining ocular tissue cell membrane integrity during contact lens wear comprising contacting the lens with an aqueous solution comprising from about 0.1 to about 10 ppm of cetylpyridinium chloride and a poly(oxypropylene)-poly(oxyethylene) block copolymer surfactant in an amount effective to clean a contact lens contacted with said solution. 
     
     
         15 . The method for disinfecting according  claim 14 , wherein the aqueous solution further comprises a component selected from the group consisting of a second antimicrobial agent, a viscosity inducing agent, a chelating agent, a buffer, taurine and a tonicity component. 
     
     
         16 . A method for maintaining ocular tissue cell membrane integrity during contact lens wear comprising contacting a lens positioned in a user's eye with an isotonic aqueous solution comprising:
 an aqueous liquid medium;   at least about 0.1 to about 10 ppm cetylpyridinium chloride;   taurine in an amount effective to protect ocular tissue cell membranes;   a poly(oxypropylene)-poly(oxyethylene) block copolymer surfactant in an amount effective to clean a contact lens contacted with said solution;   a buffer component in an amount effective in maintaining the pH of said solution within a physiologically acceptable range;   a viscosity inducing component selected from the group consisting of cellulosic derivatives and mixtures thereof in the range of about 0.05% to about 5.0% (w/v) of the total solution;   a chelating component in an amount of less than 0.05% (w/v) of the total solution;
 and a tonicity component in an amount effective in providing the desired tonicity to said solution. 
   
     
     
         17 . A process for mitigating ocular tissue insult comprising:
 administering an aqueous liquid medium to a user's eye, the aqueous liquid medium comprising:   at least about 0.1 to about 10 ppm cetylpyridinium chloride;   and a poly(oxypropylene)-poly(oxyethylene) block copolymer surfactant in an amount effective in cleaning a contact lens contacted with said solution.   
     
     
         18 . The process of  claim 17 , wherein administering step is conducted so that the aqueous liquid medium is temporarily emplaced in the user's eye. 
     
     
         19 . The process of  claim 17 , wherein administering step is conducted so that uptake of the aqueous liquid medium into at least one of a soft-contact lens and a rigid gas permeable lens is achieved. 
     
     
         20 . The process of  claim 17 , wherein the aqueous liquid medium further comprises a second antimicrobial component. 
     
     
         21 - 56 . (canceled)

Join the waitlist — get patent alerts

Track US2009318512A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.